ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

In Brief Election Results Won’t Hurt Cancer Program, May Help; Coper To Stay If Carter Wants Him

November 12, 1976

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995